Gut Microbiota and Alzheimer Disease

The hallmarks of Alzheimer’s disease (AD) include brain dysfunction and the buildup of amyloid and tau proteins. The onset of dementia is one of the latter symptoms. Imaging diagnostics allowed for the detection of amyloid buildup in the brain 10–20 years before the emergence of overt signs of the d...

Full description

Saved in:
Bibliographic Details
Main Author: Lester Raymundo Dominguez Huarcaya
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Acta Neurologica Taiwanica
Subjects:
Online Access:https://journals.lww.com/10.4103/ANT.ANT_113_0046
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849467945295544320
author Lester Raymundo Dominguez Huarcaya
author_facet Lester Raymundo Dominguez Huarcaya
author_sort Lester Raymundo Dominguez Huarcaya
collection DOAJ
description The hallmarks of Alzheimer’s disease (AD) include brain dysfunction and the buildup of amyloid and tau proteins. The onset of dementia is one of the latter symptoms. Imaging diagnostics allowed for the detection of amyloid buildup in the brain 10–20 years before the emergence of overt signs of the disease. The application of imaging diagnostic techniques allowed for this identification. Within the next few decades, the incidence and frequency of this disease are expected to reach epidemic proportions unless measures are done to stop or slow its growth. However, unless action is taken to slow or stop the disease’s progression, it will continue to threaten the health of the general public. Recently, there has been some speculation that the gut flora might contribute to the development of AD. Not only that, but the rapidly expanding ischemia etiology is another possible contributor to the issue. Rumor has it that there’s a network connecting the brain and the stomach called the “gut-brain-microbiota axis.” The hypothesis is based on this network. Furthermore, a large amount of evidence implies that the gut microbiota (GMB) could potentially contribute to the onset of AD. It has been suggested that the GMB could play a role in the onset of AD. This notion has been bolstered by new studies. It is quite probable that this review will address the prospect of a link between the microbiome and AD. This concept could be explored as a potential therapy or preventative measure. Some techniques that show promise as new treatments for AD include changes to the GMB, which can be achieved through dietary changes or positive microflora interventions, and changes to microbiological partners and their products, like amyloid protein.
format Article
id doaj-art-2ed9ae6222a34abc9df79acbb44f6c9c
institution Kabale University
issn 1028-768X
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Acta Neurologica Taiwanica
spelling doaj-art-2ed9ae6222a34abc9df79acbb44f6c9c2025-08-20T03:25:59ZengWolters Kluwer Medknow PublicationsActa Neurologica Taiwanica1028-768X2025-01-0134111210.4103/ANT.ANT_113_0046Gut Microbiota and Alzheimer DiseaseLester Raymundo Dominguez HuarcayaThe hallmarks of Alzheimer’s disease (AD) include brain dysfunction and the buildup of amyloid and tau proteins. The onset of dementia is one of the latter symptoms. Imaging diagnostics allowed for the detection of amyloid buildup in the brain 10–20 years before the emergence of overt signs of the disease. The application of imaging diagnostic techniques allowed for this identification. Within the next few decades, the incidence and frequency of this disease are expected to reach epidemic proportions unless measures are done to stop or slow its growth. However, unless action is taken to slow or stop the disease’s progression, it will continue to threaten the health of the general public. Recently, there has been some speculation that the gut flora might contribute to the development of AD. Not only that, but the rapidly expanding ischemia etiology is another possible contributor to the issue. Rumor has it that there’s a network connecting the brain and the stomach called the “gut-brain-microbiota axis.” The hypothesis is based on this network. Furthermore, a large amount of evidence implies that the gut microbiota (GMB) could potentially contribute to the onset of AD. It has been suggested that the GMB could play a role in the onset of AD. This notion has been bolstered by new studies. It is quite probable that this review will address the prospect of a link between the microbiome and AD. This concept could be explored as a potential therapy or preventative measure. Some techniques that show promise as new treatments for AD include changes to the GMB, which can be achieved through dietary changes or positive microflora interventions, and changes to microbiological partners and their products, like amyloid protein.https://journals.lww.com/10.4103/ANT.ANT_113_0046alzheimer’s diseasegut dysbiosisgut microbiotamicrobiota-gut-brain axisneuroinflammation
spellingShingle Lester Raymundo Dominguez Huarcaya
Gut Microbiota and Alzheimer Disease
Acta Neurologica Taiwanica
alzheimer’s disease
gut dysbiosis
gut microbiota
microbiota-gut-brain axis
neuroinflammation
title Gut Microbiota and Alzheimer Disease
title_full Gut Microbiota and Alzheimer Disease
title_fullStr Gut Microbiota and Alzheimer Disease
title_full_unstemmed Gut Microbiota and Alzheimer Disease
title_short Gut Microbiota and Alzheimer Disease
title_sort gut microbiota and alzheimer disease
topic alzheimer’s disease
gut dysbiosis
gut microbiota
microbiota-gut-brain axis
neuroinflammation
url https://journals.lww.com/10.4103/ANT.ANT_113_0046
work_keys_str_mv AT lesterraymundodominguezhuarcaya gutmicrobiotaandalzheimerdisease